FI954992A0 - Menetelmä tetratsolijohdannaisen valmistamiseksi kahtena kidemuotona ja mainitun johdannaisen uusi kidemuoto - Google Patents

Menetelmä tetratsolijohdannaisen valmistamiseksi kahtena kidemuotona ja mainitun johdannaisen uusi kidemuoto

Info

Publication number
FI954992A0
FI954992A0 FI954992A FI954992A FI954992A0 FI 954992 A0 FI954992 A0 FI 954992A0 FI 954992 A FI954992 A FI 954992A FI 954992 A FI954992 A FI 954992A FI 954992 A0 FI954992 A0 FI 954992A0
Authority
FI
Finland
Prior art keywords
derivative
water
ray diffraction
diffraction pattern
contg
Prior art date
Application number
FI954992A
Other languages
English (en)
Swedish (sv)
Other versions
FI954992A (fi
FI114156B (fi
Inventor
Antoine Caron
Dominique Chantreux
Colette Bouloumie
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI954992A0 publication Critical patent/FI954992A0/fi
Publication of FI954992A publication Critical patent/FI954992A/fi
Application granted granted Critical
Publication of FI114156B publication Critical patent/FI114156B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Photoreceptors In Electrophotography (AREA)
FI954992A 1994-10-19 1995-10-19 Menetelmä tetratsolijohdannaisen valmistamiseksi kahtena kidemuotona ja mainitun johdannaisen uusi kidemuoto FI114156B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9412459A FR2725987B1 (fr) 1994-10-19 1994-10-19 Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
FR9412459 1994-10-19

Publications (3)

Publication Number Publication Date
FI954992A0 true FI954992A0 (fi) 1995-10-19
FI954992A FI954992A (fi) 1996-04-20
FI114156B FI114156B (fi) 2004-08-31

Family

ID=9467986

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954992A FI114156B (fi) 1994-10-19 1995-10-19 Menetelmä tetratsolijohdannaisen valmistamiseksi kahtena kidemuotona ja mainitun johdannaisen uusi kidemuoto

Country Status (27)

Country Link
US (1) US5629331A (fi)
EP (1) EP0708103B1 (fi)
JP (1) JP3366786B2 (fi)
KR (1) KR100251222B1 (fi)
CN (1) CN1061656C (fi)
AT (1) ATE198478T1 (fi)
AU (1) AU698041B2 (fi)
CA (1) CA2160725C (fi)
CY (1) CY2277B1 (fi)
CZ (2) CZ288629B6 (fi)
DE (1) DE69519788T2 (fi)
DK (1) DK0708103T3 (fi)
ES (1) ES2155115T3 (fi)
FI (1) FI114156B (fi)
FR (1) FR2725987B1 (fi)
GR (1) GR3035503T3 (fi)
HK (1) HK1005135A1 (fi)
HU (1) HU226461B1 (fi)
IL (1) IL115688A (fi)
NO (1) NO307516B1 (fi)
NZ (1) NZ280293A (fi)
PL (1) PL184193B1 (fi)
PT (1) PT708103E (fi)
RU (1) RU2144536C1 (fi)
SI (1) SI0708103T1 (fi)
TW (1) TW357147B (fi)
ZA (1) ZA958850B (fi)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW442301B (en) * 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
US5994348A (en) 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
FR2780403B3 (fr) * 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
SK18822000A3 (sk) 1998-07-06 2001-12-03 Bristol-Myers Squibb Company Bifenylsulfónamidy ako duálne antagonisty angiotenzínového a endotelínového receptora
CA2469656A1 (en) * 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Limited Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one
US20050176794A1 (en) * 2002-07-16 2005-08-11 Ben-Zion Dolitzky Novel synthesis of irbesartan
WO2004065383A2 (en) * 2003-01-16 2004-08-05 Teva Pharmaceutical Industries Ltd. Novel synthesis of irbesartan
ATE401323T1 (de) 2003-02-05 2008-08-15 Teva Pharma Synthese von 2-butyl-3-(2'-(1-trityl-1h-tetrazol- 5-yl)biphenyl-4-yl)-1,3-diazaspiro-4,4 -nonen-4- on
AU2003242984A1 (en) * 2003-04-07 2004-11-01 Hetero Drugs Limited A novel crystalline form of irbesartan
WO2005051943A1 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Processes for the preparation of highly pure irbesartan
PL1750862T3 (pl) 2004-06-04 2011-06-30 Teva Pharma Kompozycja farmaceutyczna zawierająca irbesartan
WO2006001026A1 (en) * 2004-06-23 2006-01-05 Hetero Drugs Limited Irbesartan polymorphs
SI21849A (sl) * 2004-07-29 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava hidrokloridnih soli tetrazolskega derivata
TWI346108B (en) * 2004-08-23 2011-08-01 Bristol Myers Squibb Co A method for preparing irbesartan and intermediates thereof
GB2419592A (en) * 2004-10-26 2006-05-03 Cipla Ltd Process for the preparation of irbesartan hydrochloride
ES2454197T3 (es) * 2004-11-11 2014-04-09 Lek Pharmaceuticals D.D. Formas polimórficas de Irbesartán
ES2259909B1 (es) * 2005-02-28 2007-06-16 Inke, S.A. Procedimiento para la obtencion de un compuesto farmaceuticamente activo y de su intermedio de sintesis.
US7964737B2 (en) 2005-07-27 2011-06-21 Jubilant Organosys Limited Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one
ATE462414T1 (de) 2006-01-09 2010-04-15 Krka D D Novo Mesto Irbesartan enthaltende feste zubereitung
WO2008041957A1 (en) * 2006-10-03 2008-04-10 Ulkar Kimya Sanayi Ve Ticaret As Method for producing pure crystalline form of 2-n-butyl-3-((2-(1h-tetrazole-5-yl) (1,1'-biphenyl)-4-methyl)-1,3-diazapspiro (4,4') non -1- en-4-one
EP1918288A1 (en) 2006-11-02 2008-05-07 Cadila Pharmaceuticals Limited A novel and improved process for the preparation of Irbesartan, an angiotensin-II receptor antagonist for the treatment of hypertension
PL2065035T3 (pl) * 2007-11-28 2011-02-28 Lesvi Laboratorios Sl Preparaty farmaceutyczne zawierające irbesartan
EP2215083A2 (en) * 2007-12-07 2010-08-11 Hetero Drugs Limited Process for pure irbesartan
KR101009383B1 (ko) * 2008-04-30 2011-01-19 켐젠주식회사 고순도의2-부틸-3-[[2'-(1에이취-테트라졸-5-일)[1,1'-비페닐]-4-일]메틸]-1,3-디아자스피로[4.4]논-1-엔-4-온 화합물의제조방법
EP2417110B1 (en) * 2009-04-08 2014-05-07 CTX Life Sciences Pvt. Ltd. A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4]non-1-en-4-one (irbesartan)
AR078107A1 (es) * 2009-08-31 2011-10-12 Sanofi Aventis Uso de irbesartan para la preparacion de un medicamento para la prevencion de la hospitalizacion por insuficiencia cardiaca
US8080670B2 (en) 2010-05-04 2011-12-20 Divi's Laboratories, Ltd. Process for the preparation of irbesartan
FR2977253B1 (fr) 2011-06-30 2013-08-09 Centre Nat Rech Scient Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US11655220B2 (en) 2020-10-22 2023-05-23 Hetero Labs Limited Process for the preparation of angiotensin II receptor blockers
CA3233738A1 (en) 2021-10-01 2023-04-06 Sanofi Process for preparing sartan active compounds having a tetrazole ring

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2697919B2 (ja) * 1989-09-29 1998-01-19 キヤノン株式会社 信号内挿回路及び該回路を備えた変位測定装置
IE70593B1 (en) * 1989-09-29 1996-12-11 Eisai Co Ltd Biphenylmethane derivative the use of it and pharmacological compositions containing same
IL99372A0 (en) * 1990-09-10 1992-08-18 Ciba Geigy Ag Azacyclic compounds

Also Published As

Publication number Publication date
ES2155115T3 (es) 2001-05-01
HU9503016D0 (en) 1995-12-28
NO307516B1 (no) 2000-04-17
JPH08208642A (ja) 1996-08-13
CN1128261A (zh) 1996-08-07
AU698041B2 (en) 1998-10-22
AU3433595A (en) 1996-05-02
CA2160725C (en) 2001-12-18
KR100251222B1 (ko) 2000-05-01
DE69519788T2 (de) 2001-08-30
FR2725987A1 (fr) 1996-04-26
NO954154D0 (no) 1995-10-18
US5629331A (en) 1997-05-13
DK0708103T3 (da) 2001-04-23
NZ280293A (en) 1997-10-24
NO954154L (no) 1996-04-22
HU226461B1 (en) 2008-12-29
GR3035503T3 (en) 2001-06-29
PL311012A1 (en) 1996-04-29
DE69519788D1 (de) 2001-02-08
CZ288629B6 (cs) 2001-08-15
IL115688A0 (en) 1996-01-19
CN1061656C (zh) 2001-02-07
PL184193B1 (pl) 2002-09-30
FI954992A (fi) 1996-04-20
CZ288624B6 (cs) 2001-08-15
PT708103E (pt) 2001-06-29
RU2144536C1 (ru) 2000-01-20
SI0708103T1 (en) 2001-04-30
TW357147B (en) 1999-05-01
FR2725987B1 (fr) 1997-01-10
FI114156B (fi) 2004-08-31
JP3366786B2 (ja) 2003-01-14
HK1005135A1 (en) 1998-12-24
CZ271095A3 (en) 1996-05-15
CY2277B1 (en) 2003-07-04
HUT73179A (en) 1996-06-28
EP0708103A1 (fr) 1996-04-24
CA2160725A1 (en) 1996-04-20
ZA958850B (en) 1996-05-27
KR960014122A (ko) 1996-05-22
ATE198478T1 (de) 2001-01-15
EP0708103B1 (fr) 2001-01-03
IL115688A (en) 1999-09-22

Similar Documents

Publication Publication Date Title
FI954992A0 (fi) Menetelmä tetratsolijohdannaisen valmistamiseksi kahtena kidemuotona ja mainitun johdannaisen uusi kidemuoto
RU95118109A (ru) Способ получения производного тетразола, способ получения формы b производного тетразола, форма b производного тетразола и фармацевтическая композиция на основе производного тетразола формы b
CA2229000A1 (en) 1-biphenylimidazole derivatives, their preparation and their therapeutic use
FI972194A0 (fi) Uusia bentsyylipyrimidiinejä
NO973813L (no) Fremgangsmåte ved gjenvinning av xylose fra opplösninger
NO307932B1 (no) Tetrazolylfenylborsyremellomprodukter for syntese av AII- reseptorantagonister
AU764260B2 (en) Method of producing cyclene
KR840003250A (ko) 3-(1h-테트라졸-5-일)-4-(3h)-퀴나졸리논의 제조방법
US6156890A (en) Process for the production of cyclene
EP0398230A3 (en) Antiviral, highly water soluble, stable, crystalline salts of 2',3'-dideoxyinoside monohydrate, 2',3'-dideoxy-2',3'-didehydrothymidine monohydrate and 2',3'-dideoxy-2'-fluoroinosine hemihydrate
Jubault et al. Selective electroreduction of substituted 1, 3-thiazinic compounds
CA2081135A1 (en) Method for precipitating an organic resin from an alkaline solution thereof
FI943730A (fi) Menetelmä angiotensiini-II-antagonistina aktiivisen 3-(2'-N-bentsoyylisulfonamido-bifen-4-yyli)metyyli-5,7-dimetyyli-2-etyyli-3H-imidatso/4,5-b/pyridiinin valmistamiseksi

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: SANOFI-AVENTIS

MM Patent lapsed